first_img Jabran Khan has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. The high-calibre small-cap stock flying under the City’s radar Our 6 ‘Best Buys Now’ Shares Adventurous investors like you won’t want to miss out on what could be a truly astonishing opportunity…You see, over the past three years, this AIM-listed company has been quietly powering ahead… rewarding its shareholders with generous share price growth thanks to a carefully orchestrated ‘buy and build’ strategy.And with a first-class management team at the helm, a proven, well-executed business model, plus market-leading positions in high-margin, niche products… our analysts believe there’s still plenty more potential growth in the pipeline.Here’s your chance to discover exactly what has got our Motley Fool UK investment team all hot-under-the-collar about this tiny £350+ million enterprise… inside a specially prepared free investment report.But here’s the really exciting part… right now, we believe many UK investors have quite simply never heard of this company before! I always keep an eye on small-cap opportunities. With that in mind, I feel technology firm BATM Advanced Communications (LSE:BVC) is one such opportunity. The company is very topical too. BVC has a subsidiary that has been developing a Covid-19 test and that’s behind the recent spike in its share price.Small-cap opportunityBATM Advanced Communications is a leading provider of real-time technologies for networking and cyber security solutions for bio-medical and bio-waste treatment solutions. It operates via two divisions — Bio-Medical and Networking and Cyber Security. Headquartered in Israel, it has a global reach with offices and operations in North America, Europe and Asia too.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…When the market crashed, the small-cap was not affected as badly as some other FTSE incumbents. The BVC share price decreased just over 30% between February and March from 47p per share to 31p per share. And boy, has it bounced back! At the time of writing, the shares can be purchased for nearly 135p each.Covid-19 applications and trading updateThere are a couple of reasons behind this hike in the share price. Firstly as I mentioned, a subsidiary — Adaltis — launched a Covid-19 test kit that diagnosed if a patient has had the virus by detecting antibodies in their blood. It was news of orders being shipped to European countries that caused the share price to rise.Secondly, its interim results made good reading for current and prospective investors, in my opinion. The results for the six months to 30 June showed revenue up over 35% compared to the same period last year. As a result of this, gross operating profit jumped close to 50%. The Bio-Medical division makes up 65% of the firm’s revenue and is where most of its current burgeoning products reside. Revenue was up over 65% in this division. But Networking and Cyber Security also played its part in its growth with a 5% increase in revenue.The outlook for the remainder of the year is favourable, which makes me more confident. BVC has confirmed it has a substantial backlog of orders that it’s working hard to fulfil and both divisions are expected to report record revenue growth for 2020. Overall group revenue should be up 30% compared to 2019. You would be hard-pressed at the moment to find many other small-cap stocks reporting such positive results and future outlook. Buy now or regret it?I really like the look of BVC as a small-cap opportunity. It has a clear and solid business model within its two divisions. It seems the Bio-Medical unit is thriving especially given the Covid-19 situation. But the Networking and Cyber division is performing well quietly in the background too.At its current level, I feel it’s still a bargain, even though its share price has increased over 150% since the beginning of May. I expect this upward trend to continue. BVC is in a strong cash position too and expects to be able to pay a full dividend for 2020 which further cements my stance on the business. Jabran Khan | Thursday, 27th August, 2020 | More on: BVC Click here to claim your copy of this special investment report — and we’ll tell you the name of this Top Small-Cap Stock… free of charge! Image source: Getty Images center_img Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Simply click below to discover how you can take advantage of this. Here’s a small-cap opportunity I believe could make you money! Enter Your Email Address See all posts by Jabran Khanlast_img read more